HighTide Therapeutics (Hong Kong) Limited agreed to acquire an unknown stake in Shenzhen Hightide Biopharmaceutical, Ltd from Shenzhen Hepalink Pharmaceutical Group Co., Ltd..

HighTide Therapeutics (Hong Kong) Limited acquired an unknown stake in Shenzhen Hightide Biopharmaceutical, Ltd from Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (SZSE:002399) on January 18, 2019. The transaction has been approved by the Board of Directors of Shenzhen Hepalink Pharmaceutical Group Co., Ltd at 16th session of the 4th directorate held on January 18, 2019.